These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Synthesis and characterisation of a new benzamide-containing nitrobenzoxadiazole as a GSTP1-1 inhibitor endowed with high stability to metabolic hydrolysis. Di Paolo V; Fulci C; Rotili D; Sciarretta F; Lucidi A; Morozzo Della Rocca B; De Luca A; Rosato A; Quintieri L; Caccuri AM J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1131-1139. PubMed ID: 31169043 [TBL] [Abstract][Full Text] [Related]
45. Thiazolide-induced apoptosis in colorectal cancer cells is mediated via the Jun kinase-Bim axis and reveals glutathione-S-transferase P1 as Achilles' heel. Sidler D; Brockmann A; Mueller J; Nachbur U; Corazza N; Renzulli P; Hemphill A; Brunner T Oncogene; 2012 Sep; 31(37):4095-106. PubMed ID: 22158036 [TBL] [Abstract][Full Text] [Related]
46. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester. Nakajima T; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Abe T; Kato J; Sakon K; Naniwa Y; Tanabe H; Niitsu Y J Pharmacol Exp Ther; 2003 Sep; 306(3):861-9. PubMed ID: 12805482 [TBL] [Abstract][Full Text] [Related]
47. A tyrosine-reactive irreversible inhibitor for glutathione S-transferase Pi (GSTP1). Crawford LA; Weerapana E Mol Biosyst; 2016 May; 12(6):1768-71. PubMed ID: 27113843 [TBL] [Abstract][Full Text] [Related]
48. Glutathione transferases and development of new principles to overcome drug resistance. Sau A; Pellizzari Tregno F; Valentino F; Federici G; Caccuri AM Arch Biochem Biophys; 2010 Aug; 500(2):116-22. PubMed ID: 20494652 [TBL] [Abstract][Full Text] [Related]
49. Chemical Reactivity Window Determines Prodrug Efficiency toward Glutathione Transferase Overexpressing Cancer Cells. van Gisbergen MW; Cebula M; Zhang J; Ottosson-Wadlund A; Dubois L; Lambin P; Tew KD; Townsend DM; Haenen GR; Drittij-Reijnders MJ; Saneyoshi H; Araki M; Shishido Y; Ito Y; Arnér ES; Abe H; Morgenstern R; Johansson K Mol Pharm; 2016 Jun; 13(6):2010-25. PubMed ID: 27093577 [TBL] [Abstract][Full Text] [Related]
50. Overcoming resistance to cisplatin by inhibition of glutathione S-transferases (GSTs) with ethacraplatin micelles in vitro and in vivo. Li S; Li C; Jin S; Liu J; Xue X; Eltahan AS; Sun J; Tan J; Dong J; Liang XJ Biomaterials; 2017 Nov; 144():119-129. PubMed ID: 28834763 [TBL] [Abstract][Full Text] [Related]
51. Multifunctional Pt(iv) complexes containing a glutathione S-transferase inhibitor lead to enhancing anticancer activity and preventing metastasis of osteosarcoma cells. Chen H; Chen F; Wang X; Gou S Metallomics; 2019 Feb; 11(2):317-326. PubMed ID: 30560252 [TBL] [Abstract][Full Text] [Related]
52. Cyclopentenone prostaglandins with dienone structure promote cross-linking of the chemoresistance-inducing enzyme glutathione transferase P1-1. Sánchez-Gómez FJ; Díez-Dacal B; Pajares MA; Llorca O; Pérez-Sala D Mol Pharmacol; 2010 Oct; 78(4):723-33. PubMed ID: 20631055 [TBL] [Abstract][Full Text] [Related]
53. Structure-function relationship of thiazolide-induced apoptosis in colorectal tumor cells. Brockmann A; Strittmatter T; May S; Stemmer K; Marx A; Brunner T ACS Chem Biol; 2014 Jul; 9(7):1520-7. PubMed ID: 24810314 [TBL] [Abstract][Full Text] [Related]
54. Thiazolides inhibit growth and induce glutathione-S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells. Müller J; Sidler D; Nachbur U; Wastling J; Brunner T; Hemphill A Int J Cancer; 2008 Oct; 123(8):1797-806. PubMed ID: 18688861 [TBL] [Abstract][Full Text] [Related]
55. Role of glutathione transferases in the mechanism of brostallicin activation. Pezzola S; Antonini G; Geroni C; Beria I; Colombo M; Broggini M; Marchini S; Mongelli N; Leboffe L; MacArthur R; Mozzi AF; Federici G; Caccuri AM Biochemistry; 2010 Jan; 49(1):226-35. PubMed ID: 19950984 [TBL] [Abstract][Full Text] [Related]
56. Downregulation of GSTpi expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis. Yu ST; Chen TM; Chern JW; Tseng SY; Chen YH Anticancer Drugs; 2009 Jun; 20(5):382-8. PubMed ID: 19318911 [TBL] [Abstract][Full Text] [Related]
57. Furoxans and tocopherol analogs-furoxan hybrids as anticancer agents. Pérez F; Varela M; Canclini L; Acosta S; Martínez-López W; López GV; Hernández P Anticancer Drugs; 2019 Apr; 30(4):330-338. PubMed ID: 30489292 [TBL] [Abstract][Full Text] [Related]
58. Inhibition of human glutathione S-transferases by curcumin and analogues. Appiah-Opong R; Commandeur JN; Istyastono E; Bogaards JJ; Vermeulen NP Xenobiotica; 2009 Apr; 39(4):302-11. PubMed ID: 19350453 [TBL] [Abstract][Full Text] [Related]
59. 4-Aryl-1,3,2-oxathiazolylium-5-olate: a novel GST inhibitor to release JNK and activate c-Jun for cancer therapy. Cui H; Shen J; Lu D; Zhang T; Zhang W; Sun D; Wang PG Cancer Chemother Pharmacol; 2008 Aug; 62(3):509-15. PubMed ID: 18008069 [TBL] [Abstract][Full Text] [Related]
60. Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4. Bernardini S; Nuccetelli M; Noguera NI; Bellincampi L; Lunghi P; Bonati A; Mann K; Miller WH; Federici G; Lo Coco F Ann Hematol; 2006 Oct; 85(10):681-7. PubMed ID: 16733740 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]